Tag: Tildrakizumab Injection
Sun Pharma launches ILUMYA – Tildrakizumab
Sun Pharmaceutical Industries announced that its wholly-owned Japanese subsidiary has launched ILUMYA subcutaneous injection 100 mg syringe (nonproprietary name: tildrakizumab) in Japan...
Latest posts
Govt Job: For M.Pharm, M.Sc, Ph.D at National Innovation Foundation
The National Innovation Foundation – India, is India's national initiative to strengthen the grassroots technological innovations and outstanding traditional knowledge.